Skip to main content

RX · BioSyent Inc. · Investor Relations

16.8500 CAD -0.2000 (-1.17%) At close · Nov 3 Intraday price with Plus
Market Cap
190.39M CAD
Shares
11.23M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

No Investor Relations Content

No press releases or events have been collected for this stock yet.